Posts by John

Recent patient deaths in Chinese clinical trials have sparked concerns over regulatory oversight and the risks of prioritizing speed over safety in research.

The FDA has approved Regeneron’s Sohonos to treat fibrodysplasia ossificans progressiva. Learn how this new therapy impacts the rare bone disease market.

A new study shows promise for treating metastatic breast cancer without chemotherapy, utilizing targeted therapies to improve patient quality of life.

Bayer will present pivotal Phase III trial data on heart, kidney, and stroke treatments at ESC 2026. Discover how these findings may shift clinical care.

New clinical results show a personalized mRNA vaccine significantly prevents melanoma recurrence by training the immune system to target cancer cells.

The INSIGHTT trial has launched to test SRP-1005, a novel gene therapy aimed at lowering toxic huntingtin protein levels in Huntington’s disease patients.

PleoPharma receives a $6.5M NIDA grant to launch a Phase 3 trial for PP-01, a potential breakthrough treatment for Cannabis Use Disorder withdrawal symptoms.

Mitochon Pharmaceuticals secures a $1M grant from the ALS Association to advance Phase II clinical trials for its neuroprotective drug candidate, BED-001.

Novo Nordisk has launched a clinical trial for lower-dose oral Wegovy, aiming to improve patient compliance and reduce side effects in weight management.

Revolutionary new brain implants are now using infrared light to transmit neural signals, potentially transforming the future of medical neurotechnology.